株式会社極東書店トップ ＞ 商品一覧 ＞ Pharma M&A versus Alliances and Its Underlying Value Drivers : Are M&A or Alliances the Right Therapy for an Ailing Pharmaceutical Industry?: A Capital Market Perspective.
商品詳細
Pharma M&A versus Alliances and Its Underlying Value Drivers : Are M&A or Alliances the Right Therapy for an Ailing Pharmaceutical Industry?: A Capital Market Perspective.
・ISBN 978-3-631-66381-3 soft SFR 69.35
￥19,985.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
お気に入り
★★★
| 著者・編者 | Schön, Heiko, |
|---|---|
| シリーズ | Corporate Finance and Governance |
| 出版社 | (PL Academic Research, SZ) |
| 出版年月 | 2015 |
| ページ数 | 201 pp. |
| 言語 | ENG |
| ニュース番号 | ＜629-L658＞ |
解説
From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.